全体要約
また、2022年にはプラスミドDNA分離セグメントが市場で最大のシェアを持ち、遺伝子発現プロファイリングやその他のプロセスへの広範な応用がこのセグメントの成長を促進しています。アプリケーション分野では、診断セグメントが最大のシェアを占めており、DNAおよびRNAの分離利用が増加していることが影響しています。地域別では、北米が市場で最大のシェアを持ち、医薬品およびバイオテクノロジー企業の研究開発投資の増加や政府の支援がその要因です。
関連する質問
9.4 billion USD (2028年)
8.1% (2023年から2028年)
Thermo Fisher Scientific Inc., Merck KGaA, QIAGEN, F. Hoffmann-La Roche Ltd., Promega Corporation, Agilent Technologies, Inc., Danaher, Bio-Rad Laboratories, Inc., Illumina, Inc., Takara Bio Inc., New England Biolabs, Abcam Plc, KILPEST India Limited, Apical Scientific Sdn. Bhd., Endress+Hauser Group Services AG, GENAXXON bioscience GmbH, LGC Biosearch Technologies, Zymo Research Corporation, Norgen Biotek Corp., Omega Bio-Tek, Inc., FAVORGEN Biotech Corp., TIANGEN Biotech (Beijing) Co., Ltd., AutoGen Inc., PCR Biosystems, Biogenuix
自動化の増加、研究開発活動の増加、技術革新の進展
概要
2022年には、キットセグメントが世界の核酸分離および精製市場で最大のシェアを占めました。
製品に基づいて、核酸の分離および精製市場はキット、試薬、機器に分けられています。機器セグメントはさらに自動機器と手動機器に分かれます。2022年には、キットセグメントが世界の核酸分離および精製市場の最大のシェアを占めました。この市場の成長に寄与する要因には、分子診断、遺伝子シーケンシング、遺伝子クローニングを含むアプリケーションでのキットの使いやすさとコストが含まれ、主要な市場プレーヤーが高度なキットの開発と投入に継続的に焦点を当てていることが挙げられます。
2022年には、プラスミドDNA抽出セグメントが市場の最大のシェアを占めました。
タイプ別に、世界の核酸分離・精製市場はプラスミドDNA、総RNA、循環核酸、ゲノムDNA、メッセンジャーRNA、マイクロRNA、およびその他の核酸分離・精製タイプにセグメント化されています。2022年には、プラスミドDNAの分離・精製セグメントが世界の核酸分離・精製市場で支配的な地位を占めました。このセグメントの成長は、いくつかの要因に起因しています。まず、マーケットはプラスミドDNA専用に設計された多様な抽出および処理キットが広く利用可能であることから恩恵を受けています。さらに、遺伝子発現プロファイリングにおけるプラスミドDNAの利用が増加しており、さまざまなダウンストリームプロセスにおける広範な応用がこのセグメントの拡大に寄与しています。
2022年には、診断セグメントが世界の核酸分離・精製市場の最大のシェアを占めました。
アプリケーション別に、グローバル核酸抽出および精製市場はパーソナライズドメディスン、診断、農業および動物研究、医薬品の発見および開発、その他のアプリケーションに分かれています。2022年には、診断セグメントがグローバル核酸抽出および精製市場で優位に立ちました。このセグメントの重要性には、病原体の同定のためのルーチンなサンプル処理におけるDNAおよびRNA抽出の利用が増加していること、患者間でのゲノム診断に対する意識が高まっていること、疾病診断におけるゲノミクスシーケンシングの効率が向上していることなど、いくつかの要因が寄与しています。
2022年、北米は核酸の分離および精製市場で最大のシェアを占めました。
地域別に市場は北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東およびアフリカに分かれています。2022年には、北米が世界の核酸分離および精製市場を支配しました。この地域の支配は、主要プレーヤーの存在、製薬およびバイオテクノロジー企業の研究開発支出の増加、政府の支援、技術の進展などの要因に起因しています。
このレポートのために行われた主なインタビューは、次のように分類できます：
• 回答者別：供給側 80％、需要側 20％
• 役職別：マネージャー - 45%、CXOおよびディレクター - 30%、エグゼクティブ - 25%
地域別: 北米 -37%、ヨーロッパ -30%、アジア太平洋 -25%、ラテンアメリカ -5%、中東・アフリカ -3%
報告書に掲載された企業のリスト：
・サーモフィッシャーサイエンティフィック社（米国）
・メルクKGaA（ドイツ）
・QIAGEN（ドイツ）
F. ホフマン・ラ・ロシュ株式会社（スイス）
プロメガコーポレーション（アメリカ）
アジレント・テクノロジー株式会社（米国）
ダナハー（アメリカ）
バイオ・ラッド・ラボラトリーズ社（米国）
・イルミナ社（アメリカ）
タカラバイオ株式会社（日本）
ニューイングランド・バイオラボラトリーズ（アメリカ）
アブカム株式会社 (UK)
キルペストインディアリミテッド（インド）
アピカルサイエンティフィック社（マレーシア）
エンドレス+ハウザーグループサービスAG（スイス）
・GENAXXONバイオサイエンス GmbH（ドイツ）
• LGCバイオサーチテクノロジーズ（米国）
・ザイモリサーチコーポレーション (アメリカ)
ノルゲン・バイオテック社（カナダ）
オメガバイオテック株式会社 (米国)
・FAVORGENバイオテック株式会社（中国）
TIANGENバイオテクノロジー（北京）株式会社（中国）
• オートジェン株式会社（米国）
PCRバイオシステムズ（英国）
ビオジェニュイックス（インド）
調査範囲：この報告書は、NAIP市場の成長に影響を与える重要な要因に関する詳細な情報を包括的に網羅しています。情報には、ドライバー、制約、課題、機会が含まれています。主要な業界プレイヤーについての綿密な分析が行われており、彼らのビジネス概要、ソリューション、製品についての洞察が提供されています。さらに、報告書では、パートナーシップ、契約、新製品の発売、合併および買収、NAIP市場に関連する最近の発展など、主要な戦略についても検討されています。また、報告書は、NAIP市場エコシステムにおける新興スタートアップの競争分析も行っています。
報告書を購入する理由
この報告書は、市場のリーダーや新規参入者がNAIP市場全体およびそのサブセグメントの収益数値に最も近い近似値を提供することで役立ちます。また、ステークホルダーが競争環境をよりよく理解し、自社を適切にポジショニングし、効果的な市場戦略を立てるための洞察を得るのに役立ちます。この報告書は、ステークホルダーが市場の動向を理解し、主要な市場の推進要因、制約、機会、課題に関する情報を提供します。
このレポートは以下のポイントに関する洞察を提供します。
• 核酸抽出および精製市場の成長に影響を与える主要な推進要因（研究開発活動の増加、技術の進展と自動化の増加、分子診断の需要増）制約（自動化機器の高コスト）、機会（新興経済国での成長機会、規制及び償還の改善、分子診断及び個別化医療）、および課題（運用上の障壁と熟練プロフェッショナルの不足、代替技術の導入）。
• 製品開発/イノベーション：核酸分離および精製市場における今後のトレンド、研究開発活動、新製品の発売に関する詳細な洞察です。
・市場の発展：収益性の高い市場に関する包括的な情報 - レポートは、さまざまな地域にわたる核酸の分離および精製市場を分析しています。
市場の多様化：核酸分離および精製市場における新製品、未開拓の地域、最近の発展、そして投資に関する詳細な情報
• 競合評価：Thermo Fisher Scientific Inc.（米国）、QIAGEN（ドイツ）、Merck KGaA（ドイツ）、F. Hoffmann-La Roche Ltd.（スイス）、Promega Corporation（米国）、Agilent Technologies, Inc.（米国）、Danaher（米国）、Bio-Rad Laboratories, Inc.（米国）、Illumina, Inc.（米国）、Takara Bio Inc.（日本）、New England Biolabs（米国）、Abcam Plc（英国）、KILPEST India Limited（インド）、Apical Scientific Sdn. Bhd.（マレーシア）、Endress+Hauser Group Services AG（スイス）、GENAXXON bioscience GmbH（ドイツ）、LGC Biosearch Technologies（米国）、Zymo Research Corporation（米国）、Norgen Biotek Corp.（カナダ）、Omega Bio-Tek, Inc.（米国）、FAVORGEN Biotech Corp.（中国）、TIANGEN Biotech（北京）有限公司（中国）、AutoGen Inc.（米国）、PCR Biosystems（英国）、およびBiogenuix（インド）の主要プレーヤーの市場シェア、成長戦略、商品提供についての詳細な評価です。
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 イントロダクション 44
1.1 調査の目的 44
1.2 市場の定義 44
1.2.1 包含・除外事項 45
1.3 調査範囲 46
1.3.1 対象市場 46
1.3.2 対象年 47
1.4 通貨 47
1.5 制約 47
1.6 ステークホルダー 48
1.7 変化のサマリー 48
1.8 リセッション時のインパクト 49
2 調査手法 50
2.1 リサーチデータ 50
2.1.1 二次データ 51
2.1.2 一次データ 52
2.2 市場規模予測 53
2.2.1 プライマリー考察 56
2.3 市場成長率予測 57
2.4 データのトライアンギュレーションアプローチ 59
2.5 調査の前提 60
2.6 リスク分析 60
2.7 リセッション時のインパクト分析 60
3 エグゼクティブサマリー 63
4 更なる考察 68
4.1 核酸分離・精製市場の概要 68
4.2 北米：核酸分離・精製市場、製品および国別 69
4.3 核酸分離・精製タイプ別市場シェア 2022年 69
4.4 核酸分離・精製市場シェア（製品別）2022年 70
4.5 核酸分離・精製市場シェア、手法別 2022年 70
4.6 核酸分離・精製市場シェア（用途別）2022年 71
4.7 核酸分離・精製市場シェア、エンドユーザー別 2022年 71
4.8 核酸分離・精製市場の地理的スナップショット 72
5 市場概要 73
5.1 イントロダクション 73
5.2 市場力学 73
5.2.1 促進要因 74
- 5.2.1.1 拡大するR&D 74
- 5.2.1.2 技術の進歩と自動化の進展 76
- 5.2.1.3 増加する分子診断の需要 76
5.2.2 抑制要因 78
- 5.2.2.1 自動化機器のコストが高い 78
5.2.3 市場機会 79
- 5.2.3.1 新興国における成長機会 79
- 5.2.3.2 規制および償還シナリオの改善 80
- 5.2.3.3 分子診断学と個別化医療 81
5.2.4 課題 81
- 5.2.4.1 経営上の障壁と熟練専門家の不足 81
- 5.2.4.2 代替技術の導入 82
5.3 顧客事業にインパクトのあるトレンド/ディスラプション 82
5.4 特許分析 83
5.5 バリューチェーン分析 84
5.6 サプライチェーン分析 85
5.7 エコシステム分析 86
5.8 2023-2024年の主なカンファレンス＆イベント 88
5.9 価格分析 89
5.9.1 平均販売価格、製品別 89
5.9.2 平均販売価格、地域別 90
5.10 技術分析 90
5.11 ポーターのファイブフォース分析 91
5.11.1 新規参入の脅威 92
5.11.2 代替品の脅威 92
5.11.3 サプライヤーの交渉力 92
5.11.4 買い手の交渉力 92
5.11.5 競合・競争状況の激しさ 92
5.12 規制分析 93
5.12.1 規制機関 94
5.13 主なステークホルダーと購入基準 96
5.13.1 購買プロセスにおける主要ステークホルダー 96
5.13.2 核酸分離・精製製品の購入基準 97
6 核酸分離・精製の市場、製品別 98
6.1 イントロダクション 99
6.2 キット 99
6.3 試薬 103
6.3.1 すぐに使える試薬が成長の原動力に 103
6.4 インスツルメンツ 106
6.4.1 自動計測器 110
- 6.4.1.1 成長を促進する自動計測器のメリット 110
6.4.2 マニュアルインスツルメンツ 113
7 核酸分離・精製の市場、手法別 117
7.1 イントロダクション 118
7.2 磁気ビーズを用いた分離と精製 118
7.3 試薬を用いた単離と精製 121
7.4 カラムによる単離と精製 124
7.5 その他の単離・精製法 127
8 核酸分離・精製の市場、タイプ別 131
8.1 イントロダクション 132
8.2 プラスミドDNAの単離・精製 132
8.3 Total RNAの単離と精製 136
8.4 ゲノムDNAの単離・精製 139
8.5 メッセンジャーRNAの単離・精製 142
8.6 循環核酸分離・精製 145
8.7 microRNA の単離・精製 148
8.8 その他の核酸分離・精製タイプ 151
9 核酸分離・精製の市場、用途別 154
9.1 イントロダクション 155
9.2 診断 155
9.2.1 予測期間中、診断アプリケーションが市場を支配 155
9.3 ドラッグディスカバリー＆デベロップメント 158
9.4 パーソナライズド医療 162
9.5 農業・動物研究分野 165
9.5.1 市場成長を支える有利な資金調達シナリオ 165
9.6 その他の用途 169
10 核酸分離・精製の市場、エンドユーザー別 173
10.1 イントロダクション 174
10.2 病院・診断センター 174
10.3 学術・政府研究機関 178
10.4 製薬会社・バイオテクノロジー企業 182
10.5 受託研究機関 186
10.5.1 契約研究機関は予測期間中に着実な成長を記録 186
10.6 その他のエンドユーザー 189
11 核酸分離・精製の市場、地域別 193
11.1 イントロダクション 194
11.2 北米 194
11.2.1 米国 199
- 11.2.1.1 市場の成長を支える政府と民間の資金調達 199
11.2.2 カナダ 202
- 11.2.2.1 ゲノミクスへの投資拡大が市場需要を押し上げる 202
11.2.3 北米：リセッション時のインパクト 205
11.3 ヨーロッパ 206
11.3.1 ドイツ 209
- 11.3.1.1 ドイツが欧州市場を独占 209
11.3.2 英国 213
11.3.3 フランス 216
- 11.3.3.1 高いがん罹患率が市場成長を牽引 216
11.3.4 イタリア 220
- 11.3.4.1 政府の支援がイタリア市場の成長を促進 220
11.3.5 スペイン 223
11.3.6 その他ヨーロッパ 226
11.3.7 ヨーロッパ：リセッション時のインパクト 229
11.4 アジア太平洋 230
11.4.1 中国 235
11.4.2 日本 238
- 11.4.2.1 市場成長の原動力となる会議・ワークショップの増加 238
11.4.3 インド 241
11.4.4 韓国 244
- 11.4.4.1 各国政府の支援がこの地域の市場を牽引 244
11.4.5 その他APAC（ROAPAC） 247
11.4.6 アジア太平洋：リセッション時のインパクト 251
11.5 ラテンアメリカ 251
11.5.1 ブラジル 255
- 11.5.1.1 ブラジルがLATAM市場を支配 255
11.5.2 メキシコ 258
11.5.3 その他ラテンアメリカ 261
11.5.4 ラテンアメリカ：リセッション時のインパクト 264
11.6 中東・アフリカ 265
11.6.1 中東 268
- 11.6.1.1 分子診断と研究への関心の高まりが市場を牽引 268
11.6.2 アフリカ 271
- 11.6.2.1 成長を促進する研究調査への政府支援 271
11.6.3 中東・アフリカ：リセッション時のインパクト 274
12 競合情勢 275
12.1 イントロダクション 275
12.2 主要プレーヤーが採用するRight-to-Winアプローチ 275
12.3 収益分析 277
12.4 市場シェア分析 278
12.5 企業評価マトリックス 280
12.5.1 STARS 281
12.5.2 EMERGING LEADERS 281
12.5.3 PERVASIVE PLAYERS 281
12.5.4 PARTICIPANTS 281
12.5.5 企業フットプリント分析 283
- 12.5.5.1 企業フットプリント 283
- 12.5.5.2 製品のフットプリント 284
- 12.5.5.3 企業地域フットプリント 285
12.6 スタートアップ/中小企業評価マトリックス 287
12.6.1 PROGRESSIVE COMPANIES 287
12.6.2 RESPONSIVE COMPANIES 287
12.6.3 DYNAMIC COMPANIES 287
12.6.4 STARTING BLOCKS 287
12.6.5 競合ベンチマーキング 289
12.7 COMPETITIVE SCENARIO AND TRENDS 291
12.7.1 製品展開 291
12.7.2 ディール 292
12.7.3 その他の展開 293
13 企業プロファイル 294
13.1 主要企業 294
13.1.1 THERMO FISHER SCIENTIFIC INC 294
13.1.2 QIAGEN 312
13.1.3 F. HOFFMANN-LA ROCHE LTD 322
13.1.4 MERCK KGAA 327
13.1.5 PROMEGA CORPORATION 334
13.1.6 AGILENT TECHNOLOGIES, INC 338
13.1.7 DANAHER 341
13.1.8 BIO-RAD LABORATORIES, INC 346
13.1.9 ILLUMINA, INC 349
13.1.10 TAKARA BIO INC 352
13.1.11 NEW ENGLAND BIOLABS 357
13.1.12 ABCAM PLC 361
13.2 その他企業 364
13.2.1 KILPEST INDIA LIMITED 364
13.2.2 APICAL SCIENTIFIC SDN. BHD 365
13.2.3 ENDRESS+HAUSER GROUP SERVICES AG 366
13.2.4 GENAXXON BIOSCIENCE GMBH 367
13.2.5 LGC BIOSEARCH TECHNOLOGIES 368
13.2.6 ZYMO RESEARCH CORPORATION 369
13.2.7 NORGEN BIOTEK CORP 372
13.2.8 OMEGA BIO-TEK, INC 373
13.2.9 FAVORGEN BIOTECH CORPORATION 375
13.2.10 TIANGEN BIOTECH(BEIJING)CO., LTD 376
13.2.11 AUTOGEN INC 377
13.2.12 PCR BIOSYSTEMS 379
13.2.13 BIOGENUIX 380
14 付録 381
14.1 ディスカッションガイド 381
14.2 ナレッジストア 385
14.3 カスタマイズオプション 387
14.4 関連レポート 387
14.5 執筆者の詳細 388
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
Table of Contents
1 INTRODUCTION 44
1.1 STUDY OBJECTIVES 44
1.2 MARKET DEFINITION 44
1.2.1 INCLUSIONS & EXCLUSIONS 45
1.3 STUDY SCOPE 46
1.3.1 MARKETS COVERED 46
1.3.2 YEARS CONSIDERED 47
1.4 CURRENCY 47
1.5 LIMITATIONS 47
1.6 STAKEHOLDERS 48
1.7 SUMMARY OF CHANGES 48
1.8 RECESSION IMPACT 49
2 RESEARCH METHODOLOGY 50
2.1 RESEARCH DATA 50
2.1.1 SECONDARY DATA 51
2.1.2 PRIMARY DATA 52
2.2 MARKET SIZE ESTIMATION 53
2.2.1 PRIMARY INSIGHTS 56
2.3 MARKET GROWTH RATE PROJECTIONS 57
2.4 DATA TRIANGULATION APPROACH 59
2.5 STUDY ASSUMPTIONS 60
2.6 RISK ANALYSIS 60
2.7 RECESSION IMPACT ANALYSIS 60
3 EXECUTIVE SUMMARY 63
4 PREMIUM INSIGHTS 68
4.1 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET OVERVIEW 68
4.2 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT AND COUNTRY 69
4.3 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE, BY TYPE, 2022 69
4.4 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE, BY PRODUCT, 2022 70
4.5 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE, BY METHOD, 2022 70
4.6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE, BY APPLICATION, 2022 71
4.7 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE, BY END USER, 2022 71
4.8 GEOGRAPHICAL SNAPSHOT OF NUCLEIC ACID ISOLATION AND PURIFICATION MARKET 72
5 MARKET OVERVIEW 73
5.1 INTRODUCTION 73
5.2 MARKET DYNAMICS 73
5.2.1 DRIVERS 74
- 5.2.1.1 Increasing R&D activities 74
- 5.2.1.2 Technological advancements and increasing automation 76
- 5.2.1.3 Growing demand for molecular diagnostics 76
5.2.2 RESTRAINTS 78
- 5.2.2.1 High cost of automated instruments 78
5.2.3 OPPORTUNITIES 79
- 5.2.3.1 Growth opportunities in emerging economies 79
- 5.2.3.2 Improving regulatory and reimbursement scenario 80
- 5.2.3.3 Molecular diagnostics and personalized medicine 81
5.2.4 CHALLENGES 81
- 5.2.4.1 Operational barriers and shortage of skilled professionals 81
- 5.2.4.2 Introduction of alternative technologies 82
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82
5.4 PATENT ANALYSIS 83
5.5 VALUE CHAIN ANALYSIS 84
5.6 SUPPLY CHAIN ANALYSIS 85
5.7 ECOSYSTEM ANALYSIS 86
5.8 KEY CONFERENCES & EVENTS IN 2023-2024 88
5.9 PRICING ANALYSIS 89
5.9.1 AVERAGE SELLING PRICE, BY PRODUCT 89
5.9.2 AVERAGE SELLING PRICE, BY REGION 90
5.10 TECHNOLOGY ANALYSIS 90
5.11 PORTER’S FIVE FORCES ANALYSIS 91
5.11.1 THREAT OF NEW ENTRANTS 92
5.11.2 THREAT OF SUBSTITUTES 92
5.11.3 BARGAINING POWER OF SUPPLIERS 92
5.11.4 BARGAINING POWER OF BUYERS 92
5.11.5 INTENSITY OF COMPETITIVE RIVALRY 92
5.12 REGULATORY ANALYSIS 93
5.12.1 REGULATORY BODIES 94
5.13 KEY STAKEHOLDERS & BUYING CRITERIA 96
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 96
5.13.2 BUYING CRITERIA FOR NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS 97
6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT 98
6.1 INTRODUCTION 99
6.2 KITS 99
6.2.1 KITS TO ACCOUNT FOR LARGEST SHARE OF MARKET DURING FORECAST PERIOD 99
6.3 REAGENTS 103
6.3.1 AVAILABILITY OF READY-TO-USE REAGENTS TO DRIVE GROWTH 103
6.4 INSTRUMENTS 106
6.4.1 AUTOMATIC INSTRUMENTS 110
- 6.4.1.1 Benefits of automatic instruments to drive growth 110
6.4.2 MANUAL INSTRUMENTS 113
- 6.4.2.1 Growing demand for nucleic acid isolation and purification in research and clinical applications to drive growth 113
7 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD 117
7.1 INTRODUCTION 118
7.2 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION 118
7.2.1 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 118
7.3 REAGENT-BASED ISOLATION AND PURIFICATION 121
7.3.1 REAGENT-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER STEADY GROWTH DURING FORECAST PERIOD 121
7.4 COLUMN-BASED ISOLATION AND PURIFICATION 124
7.4.1 GROWING POPULARITY OF COLUMN-BASED ISOLATION AND PURIFICATION IN CURRENT KITS TO BOOST MARKET 124
7.5 OTHER ISOLATION AND PURIFICATION METHODS 127
8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE 131
8.1 INTRODUCTION 132
8.2 PLASMID DNA ISOLATION AND PURIFICATION 132
8.2.1 PLASMID DNA ISOLATION AND PURIFICATION TO ACCOUNT FOR LARGEST SHARE OF MARKET 132
8.3 TOTAL RNA ISOLATION AND PURIFICATION 136
8.3.1 WIDE USE OF TOTAL RNA ISOLATION AND PURIFICATION FOR RESEARCH AND DIAGNOSTIC APPLICATIONS TO BOOST MARKET 136
8.4 GENOMIC DNA ISOLATION AND PURIFICATION 139
8.4.1 IMPORTANCE OF GENOMIC DNA ISOLATION IN GENETIC-BASED TESTS TO SUPPORT GROWTH 139
8.5 MESSENGER RNA ISOLATION AND PURIFICATION 142
8.5.1 ROLE PLAYED BY MESSENGER RNA ISOLATION AND PURIFICATION IN GENE EXPRESSION AND TRANSCRIPTOMICS TO DRIVE GROWTH 142
8.6 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION 145
8.6.1 ABILITY OF CIRCULATING NAIP TO ENABLE COLLECTION OF GENETIC INFORMATION FROM BODY FLUIDS TO BOOST ADOPTION 145
8.7 MICRORNA ISOLATION AND PURIFICATION 148
8.7.1 GROWING APPLICATIONS OF MICRORNA ISOLATION AND PURIFICATION IN DRUG DEVELOPMENT RESEARCH TO FUEL GROWTH 148
8.8 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES 151
9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION 154
9.1 INTRODUCTION 155
9.2 DIAGNOSTICS 155
9.2.1 DIAGNOSTIC APPLICATIONS TO DOMINATE MARKET DURING FORECAST PERIOD 155
9.3 DRUG DISCOVERY & DEVELOPMENT 158
9.3.1 POTENTIAL OF NAIP TO HELP IN DEVELOPMENT OF DRUGS FOR RARE DISEASES TO BOOST MARKET 158
9.4 PERSONALIZED MEDICINE 162
9.4.1 RISING INCIDENCE OF CANCER AND INCREASING RESEARCH AND FUNDING TO DRIVE GROWTH 162
9.5 AGRICULTURE & ANIMAL RESEARCH 165
9.5.1 FAVORABLE FUNDING SCENARIO TO SUPPORT MARKET GROWTH 165
9.6 OTHER APPLICATIONS 169
10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER 173
10.1 INTRODUCTION 174
10.2 HOSPITALS & DIAGNOSTIC CENTERS 174
10.2.1 RISING FOCUS ON PERSONALIZED MEDICINE IN HOSPITALS TO DRIVE MARKET GROWTH 174
10.3 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES 178
10.3.1 INCREASE IN RESEARCH INTENSITY TO DRIVE USAGE OF NUCLEIC ACID ISOLATION AND PURIFICATION SYSTEMS 178
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 182
10.4.1 INCREASING NUMBER OF RESEARCH PROJECTS IN GENOMICS AND RELATED AREAS TO DRIVE SEGMENT GROWTH 182
10.5 CONTRACT RESEARCH ORGANIZATIONS 186
10.5.1 CONTRACT RESEARCH ORGANIZATIONS TO REGISTER STEADY GROWTH DURING FORECAST PERIOD 186
10.6 OTHER END USERS 189
11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION 193
11.1 INTRODUCTION 194
11.2 NORTH AMERICA 194
11.2.1 US 199
- 11.2.1.1 Government and private funding to support market growth 199
11.2.2 CANADA 202
- 11.2.2.1 Growing investments in genomics to boost market demand 202
11.2.3 NORTH AMERICA: RECESSION IMPACT 205
11.3 EUROPE 206
11.3.1 GERMANY 209
- 11.3.1.1 Germany to dominate market in Europe 209
11.3.2 UK 213
- 11.3.2.1 Government support for research through investments, funds, and grants to support market growth 213
11.3.3 FRANCE 216
- 11.3.3.1 High cancer burden to drive market growth 216
11.3.4 ITALY 220
- 11.3.4.1 Government support to drive market growth in Italy 220
11.3.5 SPAIN 223
- 11.3.5.1 High adoption of advanced diagnostic technologies to drive market growth in Spain 223
11.3.6 REST OF EUROPE 226
11.3.7 EUROPE: RECESSION IMPACT 229
11.4 ASIA PACIFIC 230
11.4.1 CHINA 235
- 11.4.1.1 China to register highest growth in nucleic acid isolation and purification market in Asia Pacific region 235
11.4.2 JAPAN 238
- 11.4.2.1 Growing number of conferences & workshops to drive market growth 238
11.4.3 INDIA 241
- 11.4.3.1 Focused initiatives in pharmaceutical & biotechnology industries to drive market growth 241
11.4.4 SOUTH KOREA 244
- 11.4.4.1 Support from governments to drive market in region 244
11.4.5 REST OF ASIA PACIFIC (ROAPAC) 247
11.4.6 ASIA PACIFIC: RECESSION IMPACT 251
11.5 LATIN AMERICA 251
11.5.1 BRAZIL 255
- 11.5.1.1 Brazil to dominate LATAM market 255
11.5.2 MEXICO 258
- 11.5.2.1 Favorable trade agreements to support imports and improve access to NAIP instruments in Mexico 258
11.5.3 REST OF LATIN AMERICA 261
11.5.4 LATIN AMERICA: RECESSION IMPACT 264
11.6 MIDDLE EAST & AFRICA 265
11.6.1 MIDDLE EAST 268
- 11.6.1.1 Growing focus on molecular diagnostics and research to drive market 268
11.6.2 AFRICA 271
- 11.6.2.1 Government support for research studies to fuel growth 271
11.6.3 MIDDLE EAST & AFRICA: RECESSION IMPACT 274
12 COMPETITIVE LANDSCAPE 275
12.1 INTRODUCTION 275
12.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 275
12.3 REVENUE ANALYSIS 277
12.4 MARKET SHARE ANALYSIS 278
12.5 COMPANY EVALUATION MATRIX 280
12.5.1 STARS 281
12.5.2 EMERGING LEADERS 281
12.5.3 PERVASIVE PLAYERS 281
12.5.4 PARTICIPANTS 281
12.5.5 COMPANY FOOTPRINT ANALYSIS 283
- 12.5.5.1 Company footprint 283
- 12.5.5.2 Company product footprint 284
- 12.5.5.3 Company regional footprint 285
12.6 START-UP/SME EVALUATION MATRIX 287
12.6.1 PROGRESSIVE COMPANIES 287
12.6.2 RESPONSIVE COMPANIES 287
12.6.3 DYNAMIC COMPANIES 287
12.6.4 STARTING BLOCKS 287
12.6.5 COMPETITIVE BENCHMARKING 289
12.7 COMPETITIVE SCENARIO AND TRENDS 291
12.7.1 PRODUCT LAUNCHES 291
12.7.2 DEALS 292
12.7.3 OTHER DEVELOPMENTS 293
13 COMPANY PROFILES 294
13.1 MAJOR PLAYERS 294
13.1.1 THERMO FISHER SCIENTIFIC INC 294
13.1.2 QIAGEN 312
13.1.3 F. HOFFMANN-LA ROCHE LTD 322
13.1.4 MERCK KGAA 327
13.1.5 PROMEGA CORPORATION 334
13.1.6 AGILENT TECHNOLOGIES, INC 338
13.1.7 DANAHER 341
13.1.8 BIO-RAD LABORATORIES, INC 346
13.1.9 ILLUMINA, INC 349
13.1.10 TAKARA BIO INC 352
13.1.11 NEW ENGLAND BIOLABS 357
13.1.12 ABCAM PLC 361
13.2 OTHER COMPANIES 364
13.2.1 KILPEST INDIA LIMITED 364
13.2.2 APICAL SCIENTIFIC SDN. BHD 365
13.2.3 ENDRESS+HAUSER GROUP SERVICES AG 366
13.2.4 GENAXXON BIOSCIENCE GMBH 367
13.2.5 LGC BIOSEARCH TECHNOLOGIES 368
13.2.6 ZYMO RESEARCH CORPORATION 369
13.2.7 NORGEN BIOTEK CORP 372
13.2.8 OMEGA BIO-TEK, INC 373
13.2.9 FAVORGEN BIOTECH CORPORATION 375
13.2.10 TIANGEN BIOTECH(BEIJING)CO., LTD 376
13.2.11 AUTOGEN INC 377
13.2.12 PCR BIOSYSTEMS 379
13.2.13 BIOGENUIX 380
14 APPENDIX 381
14.1 DISCUSSION GUIDE 381
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 385
14.3 CUSTOMIZATION OPTIONS 387
14.4 RELATED REPORTS 387
14.5 AUTHOR DETAILS 388
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021-2028 (% GROWTH) TABLE 2 US HEALTH EXPENDITURE, 2019-2022 (USD MILLION) TABLE 3 US HEALTH EXPENDITURE, 2023-2028 (USD MILLION) TABLE 4 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES TABLE 5 ESTIMATED NUMBER OF NEW CANCER CASES GLOBALLY, BY TYPE OF CANCER, 2020 VS. 2025 TABLE 6 GLOBAL CANCER INCIDENCE, BY REGION, 2020 VS. 2025 TABLE 7 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: INDICATIVE LIST OF PATENTS TABLE 8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: ECOSYSTEM ANALYSIS TABLE 9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DETAILED LIST OF CONFERENCES & EVENTS IN 2023-2024 TABLE 10 AVERAGE SELLING PRICE OF NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS, 2022-2023 (USD) TABLE 11 AVERAGE SELLING PRICE OF NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS, BY REGION, 2022-2023 (USD) TABLE 12 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: PORTER’S FIVE FORCES ANALYSIS TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 17 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 18 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 19 NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 20 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 21 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 22 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 23 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 24 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 25 NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 26 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 27 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 28 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 29 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 30 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 31 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 32 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 33 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 34 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 35 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 36 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 37 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 38 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY REGION, 2021-2028 (USD MILLION) TABLE 39 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 40 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 41 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 42 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 43 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY REGION, 2021-2028 (USD MILLION) TABLE 44 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY REGION, 2021-2028 (USD MILLION) TABLE 45 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 46 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 47 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 48 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 49 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY REGION, 2021-2028 (USD MILLION) TABLE 50 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION) TABLE 51 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 52 NORTH AMERICA: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 53 EUROPE: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 54 ASIA PACIFIC: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 55 LATIN AMERICA: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 56 MIDDLE EAST & AFRICA: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 57 REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 58 NORTH AMERICA: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 59 EUROPE: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 60 ASIA PACIFIC: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 61 LATIN AMERICA: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 62 MIDDLE EAST & AFRICA: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 63 COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 64 NORTH AMERICA: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 65 EUROPE: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 66 ASIA PACIFIC: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 67 LATIN AMERICA: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 68 MIDDLE EAST & AFRICA: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 69 OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 70 NORTH AMERICA: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 71 EUROPE: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 72 ASIA PACIFIC: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 73 LATIN AMERICA: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 74 MIDDLE EAST & AFRICA: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 75 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 76 PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 77 NORTH AMERICA: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 78 EUROPE: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 79 ASIA PACIFIC: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 80 LATIN AMERICA: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 81 MIDDLE EAST & AFRICA: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 82 TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 83 NORTH AMERICA: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 84 EUROPE: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 85 ASIA PACIFIC: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 86 LATIN AMERICA: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 87 MIDDLE EAST & AFRICA: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 88 GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 89 NORTH AMERICA: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 90 EUROPE: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 91 ASIA PACIFIC: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 92 LATIN AMERICA: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 93 MIDDLE EAST & AFRICA: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 94 MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 95 NORTH AMERICA: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 96 EUROPE: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 97 ASIA PACIFIC: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 98 LATIN AMERICA: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 99 MIDDLE EAST & AFRICA: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 100 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 101 NORTH AMERICA: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 102 EUROPE: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 103 ASIA PACIFIC: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 104 LATIN AMERICA: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 105 MIDDLE EAST & AFRICA: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 106 MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 107 NORTH AMERICA: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 108 EUROPE: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 109 ASIA PACIFIC: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 110 LATIN AMERICA: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 111 MIDDLE EAST & AFRICA: MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 112 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 113 NORTH AMERICA: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 114 EUROPE: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 115 ASIA PACIFIC: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 116 LATIN AMERICA: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 117 MIDDLE EAST & AFRICA: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 118 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 119 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2021-2028 (USD MILLION) TABLE 120 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 121 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 122 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 123 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 124 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2021-2028 (USD MILLION) TABLE 125 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2021-2028 (USD MILLION) TABLE 126 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 127 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 128 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 129 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 130 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2021-2028 (USD MILLION) TABLE 131 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY REGION, 2021-2028 (USD MILLION) TABLE 132 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 133 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 134 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 135 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 136 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY REGION, 2021-2028 (USD MILLION) TABLE 137 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY REGION, 2021-2028 (USD MILLION) TABLE 138 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 139 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 140 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 141 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 142 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY REGION, 2021-2028 (USD MILLION) TABLE 143 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION) TABLE 144 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 145 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 146 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 147 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 148 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION) TABLE 149 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 150 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2021-2028 (USD MILLION) TABLE 151 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 152 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 153 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 154 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 155 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2021-2028 (USD MILLION) TABLE 156 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION) TABLE 157 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 158 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 159 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 160 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 161 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION) TABLE 162 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION) TABLE 163 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 164 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 165 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 166 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 167 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION) TABLE 168 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021-2028 (USD MILLION) TABLE 169 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 170 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 171 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 172 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 173 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021-2028 (USD MILLION) TABLE 174 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION) TABLE 175 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 176 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 177 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 178 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 179 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION) TABLE 180 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 181 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 182 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION) TABLE 183 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 184 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 185 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 186 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 187 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 188 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION) TABLE 189 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 190 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 191 US: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 192 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 193 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 194 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION) TABLE 195 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 196 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 197 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 198 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 199 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 200 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 201 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION) TABLE 202 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 203 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 204 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 205 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 206 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 207 CANCER INCIDENCE IN GERMANY, BY TYPE, 2020 VS. 2027 TABLE 208 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION) TABLE 209 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 210 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 211 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 212 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 213 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 214 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION) TABLE 215 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 216 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 217 UK: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 218 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 219 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 220 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION) TABLE 221 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 222 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 223 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 224 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 225 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 226 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION) TABLE 227 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 228 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 229 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 230 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 231 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 232 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION) TABLE 233 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 234 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 235 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 236 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 237 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 238 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION) TABLE 239 REST OF EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 240 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 241 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 242 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 243 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 244 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 245 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION) TABLE 246 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 247 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 248 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 249 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 250 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 251 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION) TABLE 252 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 253 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 254 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 255 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 256 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 257 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION) TABLE 258 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 259 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 260 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 261 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 262 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 263 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION) TABLE 264 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 265 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 266 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 267 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 268 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 269 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION) TABLE 270 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 271 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 272 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 273 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 274 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 275 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION) TABLE 276 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 277 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 278 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 279 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 280 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 281 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 282 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION) TABLE 283 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 284 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 285 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 286 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 287 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 288 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION) TABLE 289 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 290 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 291 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 292 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 293 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 294 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION) TABLE 295 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 296 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 297 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 298 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 299 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 300 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION) TABLE 301 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 302 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 303 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 304 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 305 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 306 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 307 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION) TABLE 308 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 309 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 310 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 311 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 312 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 313 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION) TABLE 314 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 315 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 316 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 317 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 318 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 319 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION) TABLE 320 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 321 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 322 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 323 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 324 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 325 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: STRATEGIES ADOPTED TABLE 326 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DEGREE OF COMPETITION TABLE 327 COMPANY FOOTPRINT ANALYSIS: KEY PLAYERS TABLE 328 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS TABLE 329 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS TABLE 330 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS TABLE 331 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS TABLE 332 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: PRODUCT LAUNCHES, JANUARY 2020-OCTOBER 2023 TABLE 333 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DEALS, JANUARY 2020 TO OCTOBER 2023 TABLE 334 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: OTHER DEVELOPMENTS, JANUARY 2020 TO OCTOBER 2023 TABLE 335 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW TABLE 336 QIAGEN: BUSINESS OVERVIEW TABLE 337 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW TABLE 338 MERCK KGAA: BUSINESS OVERVIEW TABLE 339 PROMEGA CORPORATION: BUSINESS OVERVIEW TABLE 340 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW TABLE 341 DANAHER: BUSINESS OVERVIEW TABLE 342 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW TABLE 343 ILLUMINA, INC.: BUSINESS OVERVIEW TABLE 344 TAKARA BIO INC.: BUSINESS OVERVIEW TABLE 345 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW TABLE 346 ABCAM PLC: BUSINESS OVERVIEW TABLE 347 KILPEST INDIA LIMITED: COMPANY OVERVIEW TABLE 348 APICAL SCIENTIFIC SDN. BHD.: COMPANY OVERVIEW TABLE 349 ENDRESS+HAUSER GROUP SERVICES AG: COMPANY OVERVIEW TABLE 350 GENAXXON BIOSCIENCE GMBH: COMPANY OVERVIEW TABLE 351 LGC BIOSEARCH TECHNOLOGIES: COMPANY OVERVIEW TABLE 352 ZYMO RESEARCH CORPORATION: COMPANY OVERVIEW TABLE 353 NORGEN BIOTEK CORP.: COMPANY OVERVIEW TABLE 354 OMEGA BIO-TEK, INC.: COMPANY OVERVIEW TABLE 355 FAVORGEN BIOTECH CORPORATION: COMPANY OVERVIEW TABLE 356 TIANGEN BIOTECH(BEIJING)CO., LTD.: COMPANY OVERVIEW TABLE 357 AUTOGEN INC.: COMPANY OVERVIEW TABLE 358 PCR BIOSYSTEMS: COMPANY OVERVIEW TABLE 359 BIOGENUIX: COMPANY OVERVIEW
FIGURE 1 RESEARCH DESIGN FIGURE 2 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BREAKDOWN OF PRIMARIES FIGURE 3 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: MARKET SIZE ESTIMATION FOR SUPPLY-SIDE ANALYSIS (2022) FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS) FOR 2022 FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS FOR 2022 FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS FIGURE 7 TOP-DOWN APPROACH FIGURE 8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: CAGR PROJECTIONS FOR FORECAST PERIOD FIGURE 9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES FIGURE 10 DATA TRIANGULATION METHODOLOGY FIGURE 11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) FIGURE 12 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2023 VS. 2028 (USD MILLION) FIGURE 13 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) FIGURE 14 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) FIGURE 15 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) FIGURE 16 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: GEOGRAPHIC SNAPSHOT FIGURE 17 TECHNOLOGICAL ADVANCEMENTS AND INCREASED AUTOMATION TO DRIVE MARKET GROWTH FIGURE 18 KITS DOMINATED NORTH AMERICAN NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS MARKET IN 2023 FIGURE 19 PLASMID DNA ISOLATION AND PURIFICATION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 FIGURE 20 KITS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 FIGURE 21 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2022 FIGURE 22 DIAGNOSTICS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 FIGURE 23 HOSPITALS & DIAGNOSTIC CENTERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 FIGURE 24 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD FIGURE 25 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FIGURE 26 REVENUE SHIFT & NEW REVENUE POCKETS FOR NUCLEIC ACID ISOLATION AND PURIFICATION MARKET PROVIDERS FIGURE 27 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: PATENT APPLICATIONS, OCTOBER 2013-OCTOBER 2023 FIGURE 28 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: VALUE CHAIN ANALYSIS FIGURE 29 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: SUPPLY CHAIN ANALYSIS FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS FIGURE 31 KEY BUYING CRITERIA FOR END USERS FIGURE 32 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT FIGURE 33 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS (2018-2022) FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS (2022) FIGURE 36 COMPANY EVALUATION MATRIX, 2022 FIGURE 37 START-UP/SME EVALUATION MATRIX, 2022 FIGURE 38 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022) FIGURE 39 QIAGEN: COMPANY SNAPSHOT (2022) FIGURE 40 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022) FIGURE 41 MERCK KGAA: COMPANY SNAPSHOT (2022) FIGURE 42 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022) FIGURE 43 DANAHER: COMPANY SNAPSHOT (2022) FIGURE 44 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022) FIGURE 45 ILLUMINA, INC.: COMPANY SNAPSHOT (2022) FIGURE 46 TAKARA BIO INC.: COMPANY SNAPSHOT (2022) FIGURE 47 ABCAM PLC: COMPANY SNAPSHOT (2022)
